These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 16078679

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM, Iltz JL, Fincham JE, Campbell RK, Baker DE.
    Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Advances in application of sildenafil to erectile dysfunction].
    Li Z, Wu ZM, Wang YX.
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):473-6. PubMed ID: 15999498
    [Abstract] [Full Text] [Related]

  • 5. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
    Hatzichristou D, Haro JM, Martin-Morales A, von Keitz A, Riley A, Bertsch J, Belger M, Wolka AM, Beardsworth A, EDOS Group.
    Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
    [Abstract] [Full Text] [Related]

  • 6. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?
    Doggrell S.
    Int J Impot Res; 2007 Nov; 19(3):281-95. PubMed ID: 17183346
    [Abstract] [Full Text] [Related]

  • 7. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I, Montorsi F, Jackson G, Mirone V, Chan ML, Loughney K, Vail GM, Beardsworth A.
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UK.
    Kell PD, Hvidsten K, Morant SV, Harnett JP, Bridge S.
    BJU Int; 2007 Apr; 99(4):860-3. PubMed ID: 17378846
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS).
    Martin-Morales A, Haro JM, Beardsworth A, Bertsch J, Kontodimas S, EDOS Group.
    Eur Urol; 2007 Feb; 51(2):541-50; discussion 550. PubMed ID: 17084518
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study.
    Safarinejad MR, Kolahi AA, Ghaedi G.
    BJU Int; 2009 Aug; 104(3):376-83. PubMed ID: 19389004
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the efficacy and safety of sildenafil citrate in the geriatric population.
    Müller A, Smith L, Parker M, Mulhall JP.
    BJU Int; 2007 Jul; 100(1):117-21. PubMed ID: 17552959
    [Abstract] [Full Text] [Related]

  • 17. Phosphodiesterase type 5 inhibitors: the day after.
    Hatzimouratidis K, Hatzichristou D.
    Eur Urol; 2007 Jan; 51(1):75-88; discussion 89. PubMed ID: 16949200
    [Abstract] [Full Text] [Related]

  • 18. Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors.
    Taylor J, Baldo OB, Storey A, Cartledge J, Eardley I.
    BJU Int; 2009 May; 103(10):1392-5. PubMed ID: 19154494
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.